Cargando…
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
OBJECTIVE: To determine whether the use of angiotensin converting enzyme inhibitors (ACEIs), compared with use of angiotensin receptor blockers, is associated with an increased risk of lung cancer. DESIGN: Population based cohort study. SETTING: United Kingdom Clinical Practice Research Datalink. PA...
Autores principales: | Hicks, Blánaid M, Filion, Kristian B, Yin, Hui, Sakr, Lama, Udell, Jacob A, Azoulay, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199558/ https://www.ncbi.nlm.nih.gov/pubmed/30355745 http://dx.doi.org/10.1136/bmj.k4209 |
Ejemplares similares
-
Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
por: Lapi, Francesco, et al.
Publicado: (2013) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Angiotensin‐converting enzyme inhibitors and risk of age‐related macular degeneration in individuals with hypertension
por: Subramanian, Anuradhaa, et al.
Publicado: (2022) -
Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
por: Yu, Zhiyin, et al.
Publicado: (2023)